Telmitan Plus 80 mg+12.5 mg (Tablet)
Unit Price: ৳ 20.00 (1 x 14: ৳ 280.00)
Strip Price: ৳ 280.00
Medicine Details
Category | Details |
---|---|
Generic | Telmisartan hydrochlorothiazide |
Company | Opsonin pharma ltd |
Also available as |
Indications
- Treatment of hypertension
- Lowering blood pressure
- Reducing risk of cardiovascular events
- Use alone or with other antihypertensive agents
Pharmacology
- Telmisartan: Blocks vasoconstrictor and aldosteronesecreting effects
- Telmisartan: Blocks binding of angiotensin II to AT1 receptor
- Telmisartan: Greater affinity for AT1 receptor than AT2 receptor
- Hydrochlorothiazide: Affects renal tubular mechanisms of electrolyte reabsorption
Dosage & Administration
- Initial dose of Telmisartan monotherapy 80 mg
- Titration to 160 mg/25 mg after 2 to 4 weeks if necessary
- May be administered with other antihypertensive drugs
Interaction
- Caution with aliskiren, digoxin, lithium, other high blood pressure medicines
- Caution with NSAIDs, corticosteroids, ACE blockers, angiotensin II receptor blockers
- Potential interference with certain laboratory tests
Contraindications
- Hypersensitivity to Telmisartan, Hydrochlorothiazide or any other component
- Do not co-administer Aliskiren with this tablet in patients with Diabetes
Side Effects
- Dizziness
- Drowsiness
- Flushing
- Nausea
- Diarrhea
- Allergy
- Fever
- Leg pain
- Chest pain
- Insomnia
Pregnancy & Lactation
- Pregnancy Category D
- Discontinue use when pregnancy is detected
- Potential presence of telmisartan in human milk
- Thiazides appear in human milk
Precautions & Warnings
- Caution in patients with kidney disease, liver disease, dehydration, gout, lupus
- Regular blood sugar checks for diabetic patients
- Caution with potassium supplements or salt substitutes
- May cause dizziness
Use in Special Populations
- Safety and effectiveness not established in pediatric patients
- Cautious dose selection for elderly patients
- Initiate treatment under close medical supervision in patients with hepatic impairment
Overdose Effects
- Manifestations include hypertension, dizziness, tachycardia
- Manifestations include hypokalemia, hyponatremia, dehydration
- Telmisartan not removed by hemodialysis
Therapeutic Class
- Combined antihypertensive preparations
Storage Conditions
- Keep in a cool and dry place
- Protect from light
Related Brands
- Mitosan Plus 40 mg+12.5 mg (Tablet) - sandoz-a-novartis-division
- Mitosan Plus 80 mg+12.5 mg (Tablet) - sandoz-a-novartis-division
- Telcardis Plus 40 mg+12.5 mg (Tablet) - unimed-unihealth-pharmaceuticals-ltd
- Telcardis Plus 80 mg+12.5 mg (Tablet) - unimed-unihealth-pharmaceuticals-ltd
- Arbitel Plus 40 mg+12.5 mg (Tablet) - aci-limited